Inventor · Frankfurt am Main, DE

Andreas Evers

32Patents
5h-index
36Co-inventors
65Inventor score

Filing activity: May 22, 2009 → Oct 28, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US9181305B2 Exendin-4 peptide analogues Emerging Cross-Sectional Technologies 20 Active
US9750788B2 Non-acylated exendin-4 peptide analogues Chemistry; Metallurgy 10 Active
US9365632B2 Exendin-4 derivatives as dual GLP1/glucagon agonists Emerging Cross-Sectional Technologies 6 Active
US9758561B2 Dual GLP-1/glucagon receptor agonists derived from exendin-4 Human Necessities 5 Active
US9745360B2 Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists Emerging Cross-Sectional Technologies 5 Active
US8580777B2 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Chemistry; Metallurgy 4 Active
US9751926B2 Dual GLP-1/GIP receptor agonists Chemistry; Metallurgy 3 Active
US9775904B2 Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists Chemistry; Metallurgy 3 Active
US9126955B2 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Chemistry; Metallurgy 3 Active
US9771406B2 Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 Chemistry; Metallurgy 3 Active
US9694053B2 Dual GLP-1/glucagon receptor agonists Chemistry; Metallurgy 3 Active
US8722655B2 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia Chemistry; Metallurgy 3 Active
US9789165B2 Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists Chemistry; Metallurgy 3 Active
US9309207B2 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Chemistry; Metallurgy 2 Active
US9670261B2 Functionalized exendin-4 derivatives Emerging Cross-Sectional Technologies 2 Active
US10583174B2 FGF21 compound / GLP-1R agonist combinations with optimized activity ratio Chemistry; Metallurgy 2 Active
US10792367B2 Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid Chemistry; Metallurgy 1 Active
US9982029B2 Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists Human Necessities 1 Active
US10519211B2 Compounds as peptidic GLP1/glucagon/GIP receptor agonists Chemistry; Metallurgy 1 Active
US10758592B2 Exendin-4 derivatives as dual GLP1/glucagon agonists Emerging Cross-Sectional Technologies 0 Active
US11141489B2 Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid Chemistry; Metallurgy 0 Active
US10806797B2 Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate Human Necessities 0 Active
US9932381B2 Exendin-4 derivatives as selective glucagon receptor agonists Human Necessities 0 Active
US9221784B2 Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists Chemistry; Metallurgy 0 Active
US11046743B2 Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.